357 Results (Page 2 of 15)
Vietnam Markets Research Reports
Vietnam Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Vietnam Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Vietnam Conjunctivitis Therapeutics Market Analysis
The Vietnam Conjunctivitis Therapeutics Market was valued at $21 Mn in 2022 and is predicted to grow at a CAGR of 5.63% from 2023 to 2030, to $32 Mn by 2030. The key drivers of this industry include the increasing prevalence of conjunctivitis, expanding healthcare infrastructure, and increasing treatment options. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Novartis, Rohto, Santen, Pfizer, and Mentholatum among others.
Vietnam Chronic Cough Therapeutics Market Analysis
Vietnam Chronic Cough Therapeutics Market was valued at $32 Mn in 2022 and is estimated to reach $60 Mn in 2030, exhibiting a CAGR of 8.33% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Abbott Laboratories, Merck, Teva Pharmaceuticals, Mekophar, Traphaco and Sao Thai Duong.
Vietnam Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Vietnam's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy and expert insights.
Vietnam Electronic Health Records Market Analysis
Vietnam's Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Vietnam's EHR market growth is due to the government working on improving the legal framework for healthcare IT systems to ensure data security and privacy. The market is segmented, by application type, and end user. The key market players are FPT, Tri Viet, Allscripts, Cerner, and others.
Vietnam Connected Healthcare Market Analysis
The Vietnam-connected healthcare market is projected to grow from $331.8 Mn in 2022 to $2486.65 Mn by 2030, registering a CAGR of 28.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, improved healthcare infrastructure, rising healthcare spending, and growing demand for remote healthcare. The market is segmented by type, function and by application. Some of the major players include Viettel Group, eDoctor, Med247, Samsung, IBM and GE Healthcare.
Vietnam Growth Hormone Deficiency Clinical Trials Market Analysis
This report presents a strategic analysis of the Vietnam Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Vietnam Cardiac Monitoring Devices Market Analysis
This report presents a strategic analysis of the Vietnam Cardiac Monitoring Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Cardiac Monitoring Devices Market, offering unmatched value, accuracy and expert insights.
Vietnam Breast Cancer Therapeutics Market Analysis
The sharp increase in breast cancer cases and introduction of advanced therapeutics for the treatment of breast cancer has contributed significantly to the growth of Vietnam breast cancer therapeutics market from $91 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the period 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. ImexPharm Pharmaceutical Joint Stock Company, Merck, and Syndax are some of the leading companies in the Vietnam breast cancer therapeutics market.
Vietnam Neurology Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Vietnam Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
Vietnam Cardiovascular Diseases Therapeutics Market Analysis
Vietnam's cardiovascular disease therapeutics market is projected to grow from $813 Mn in 2022 to $1,445 Mn in 2030 with a CAGR of 7.45% for the year 2022-2030. The rising incidence of cardiovascular diseases in Vietnam and increases governmental efforts in improving Vietnam's health infrastructure have resulted in the expansion of the market. The Vietnam cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Ha, Tay Pharmaceutical, OPC Pharmaceutical, and F. Hoffmann-La Roche are the major players in the Vietnam cardiovascular disease therapeutics market.
Vietnam Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the Vietnam Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
Vietnam Artificial Intelligence (AI) in Healthcare Market Analysis
Vietnam's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.03 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by the improvement in regulatory frameworks and collaboration between government, industry, and academia. The market is segmented by healthcare components & by healthcare applications. Some of the major players include GE Healthcare, IBM Watson Health & VinBrain.
Vietnam COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Vietnam COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Vietnam Dental Care Market Analysis
Vietnam's dental care market was valued at $6.595 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.93% from 2022 to 2030 and will reach $15.122 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality is technological advancement. The market is segmented by services, dental clinics, and revenue. Some key players in this market are Nha Khoa Kim, Nha Khoa Paris Dental Group, Nha Khoa Dang Luu, Anna Dental Care, etc.
Vietnam Cardiac Arrhythmia Therapeutics Market Analysis
Vietnam Cardiac Arrhythmia Therapeutics Market valued at $36 Mn in 2022, projected to reach $58 Mn by 2030 with a 6.03% CAGR. The key drivers of this industry include the rising incidence of cardiac arrhythmias, government initiatives, and increasing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Mylan, Sun Pharma, Novartis, Bayer, Fresenius, Johnson & Johnson, and Medtronic among others.
Vietnam Alzheimer’s Therapeutics Market Analysis
Vietnam alzheimer’s therapeutics market valued at $24 Mn in 2022, projected to reach $49 Mn by 2030 with a 9.33% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is the main factor driving the market for drugs used to treat the condition. The top pharmaceutical firms in the industry currently operating in the market are Eisai, Biogen, GlaxoSmithKline, Novartis, Pfizer, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and Merck & Co.
Vietnam Infectious Disease Drugs Market Analysis
Vietnam Infectious Disease Drugs Market valued at $0.59 Bn in 2023, projected to reach $0.81 Bn by 2030 with a 4.5% CAGR. The industry is influenced by factors such as government healthcare programs, rising infectious disease prevalence, and technological improvements. The market is dominated by key players like Mekophar, Hau Giang Pharmaceutical, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Vietnam Atopic Dermatitis Therapeutics Market Analysis
The Vietnam Atopic Dermatitis Therapeutics Market was valued at US $62 Mn in 2022, and is predicted to grow at (CAGR) of 9.03% from 2023 to 2030, to US $123 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), improving healthcare infrastructure, shifting patient preferences, and others. The industry is primarily dominated by players such as Sanofi, Pharmacity, Merck, AbbVie, Domesco, Novartis, and Johnson & Johnson, among others.
Vietnam Atherosclerosis Therapeutics Market Analysis
Vietnam Atherosclerosis Therapeutics Market was valued at $14 Mn in 2022 and is estimated to reach $22 Mn in 2030, exhibiting a CAGR of 5.93% during the forecast period. The rising prevalence of cardiovascular diseases, exacerbated by unhealthy dietary patterns, sedentary lifestyles, and a growing aging population worldwide, is anticipated to increase the need for atherosclerosis therapeutics. Leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott, Eli Lilly, Roche, Teva Pharmaceutical and Johnson & Johnson.
Vietnam Asthma and COPD Therapeutics Market Analysis
The Vietnam Asthma and COPD Therapeutics Market was valued at US $167 Mn in 2022, and is predicted to grow at (CAGR) of 5.43% from 2023 to 2030, to US $255 Mn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and asthma, supportive government initiatives, improved healthcare infrastructure, and others. The industry is primarily dominated by players such as Abbott, Mekophar, AstraZeneca, Traphaco, Novartis, Pharimexco, and GSK, among others.
Vietnam Anemia Therapeutics Market Analysis
The Vietnam Anemia Therapeutics Market is anticipated to experience a growth from $74 Mn in 2022 to $151 Mn by 2030, with a CAGR of 9.3% during the forecast period of 2022-2030. High anemia prevalence, changing demographic trends and urbanization, and increased government support in the betterment of healthcare access among the population are among some factors that boost Vietnam market. The Vietnam Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Roche, Bayer, Johnson & Johnson, Sanofi, AstraZeneca, Traphaco, Mekophar, Sao Kim Pharmaceutical etc, among various others
Vietnam HIV Drugs Market Analysis
Vietnam HIV Drugs Market is at around $0.16 Bn in 2023 and is projected to reach $0.21 Bn in 2030, exhibiting a CAGR of 3.83% during the forecast period. Rising expenditure on healthcare, innovation in drug development, and international alliances and funding drive growth in the market. The market is dominated by key players like Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffmann-La Roche Ltd., Novartis, and Mylan.
Vietnam Antifungal Drugs Market Analysis
Vietnam Antifungal Drugs Market is at around $0.07 Bn in 2023 and is projected to reach $0.01 Bn in 2030, exhibiting a CAGR of 4.03% during the forecast period. The market is expanding due to factors like changing lifestyles and urbanization, improvements in healthcare infrastructure, and increased public awareness of fungal infections. The market is dominated by key players like Sanofi-Aventis, Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
